Impedimed: The Future Is Now
Stockbroker
Impedimed is a revolutionary medical technology company, developing and commercialising healthcare devices based on a proprietary technology that allows the rapid, accurate and non-invasive measurement of different tissues in the body. Following the release of new guidelines by the FDA that allow companies to market low-risk products for health and wellness without going through an FDA review process, IPD launched a consumer version of its new, electrode-free device it has christened SOZO. SOZO has generated a lot of interest with a promotional video attracting over 1.7M views on YouTube since it was posted just over 2 weeks ago. In the meantime, the company is making strong headway with its lymphoedema monitoring product that is in full commercial launch in the US. The company also plans to file a 510(k) application that will open up medical markets for SOZO. The first application the company intends to tackle is monitoring patients with heart failure which affects over 5 million people in the US alone. Livewire subscribers can read our latest note in full here: (VIEW LINK)
1 stock mentioned
Canaccord Genuity Group is a leading independent, full-service financial services firm. Canaccord Genuity has been driven by an unwavering commitment to building lasting client relationships. We achieve this by generating value for our individual,...
Expertise
No areas of expertise
Canaccord Genuity Group is a leading independent, full-service financial services firm. Canaccord Genuity has been driven by an unwavering commitment to building lasting client relationships. We achieve this by generating value for our individual,...
Expertise
No areas of expertise